Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects

Psychopharmacology (Berl). 2016 Aug;233(15-16):2933-41. doi: 10.1007/s00213-016-4338-2. Epub 2016 May 27.

Abstract

Rationale: Self-titration is well documented in the tobacco literature. The extent to which e-cigarette users (vapers) self-titrate is unknown.

Objective: This study explored the effects of high and low nicotine strength liquid on puffing topography, nicotine delivery and subjective effects in experienced vapers.

Methods: Eleven experienced male vapers completed 60 min of ad libitum vaping under low (6 mg/mL) and high (24 mg/mL) nicotine liquid conditions in two separate sessions. Measurements included puffing topography (puff number, puff duration, volume of liquid consumed) and changes in plasma nicotine levels, craving, withdrawal symptoms, self-reported hit, satisfaction and adverse effects.

Results: Liquid consumption and puff number were higher and puff duration longer, in the low nicotine strength condition (all ps < 0.01). The mean difference in nicotine boost from baseline in the low condition was 8.59 (7.52) ng/mL, 16.99 (11.72) ng/mL and 22.03 (16.19) ng/mL at 10, 30 and 60 min, respectively. Corresponding values for the high condition were 33.77 (34.88) ng/mL, 35.48 (28.31) ng/mL and 43.57 (34.78) ng/mL (ps < 0.05). There were no statistically significant differences between conditions in self-reported craving, withdrawal symptoms, satisfaction, hit or adverse effects.

Conclusions: Vapers engaged in compensatory puffing with lower nicotine strength liquid, doubling their consumption. Whilst compensatory puffing was sufficient to reduce craving and withdrawal discomfort, self-titration was incomplete with significantly higher plasma nicotine levels in the high condition.

Keywords: Compensation; E-cigarette; Nicotine; Puffing topography; Titration.

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Electronic Nicotine Delivery Systems*
  • Humans
  • Male
  • Middle Aged
  • Nicotine / administration & dosage*
  • Nicotine / blood
  • Nicotinic Agonists / administration & dosage*
  • Nicotinic Agonists / blood
  • Self Administration
  • Self Report
  • Substance Withdrawal Syndrome / prevention & control*
  • Time Factors
  • Tobacco Use Disorder / physiopathology*
  • Vaping*
  • Young Adult

Substances

  • Nicotinic Agonists
  • Nicotine